Scilex Holding Co
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
SCLX$1.74+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(In thousands, except for par value and share amounts)
| March 31,2025 | December 31,2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $5,800 | $3,272 |
| Accounts receivable, net | 10,619 | 26,442 |
| Inventory | 3,017 | 2,436 |
| Prepaid expenses and other current assets | 9,268 | 9,397 |
| Total current assets | 28,704 | 41,547 |
| Property and equipment, net | 707 | 708 |
| Operating lease right-of-use asset | 2,049 | 2,225 |
| Intangibles, net | 31,451 | 32,453 |
| Investments | 2,465 | 2,420 |
| Goodwill | 13,481 | 13,481 |
| Other long-term assets | 119 | 119 |
| Total assets | $78,976 | $92,953 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $57,257 | $52,620 |
| Accrued payroll | 1,654 | 1,505 |
| Accrued rebates and fees | 168,429 | 162,517 |
| Accrued expenses | 3,482 | 2,841 |
| Current portion of deferred consideration | 437 | 447 |
| Debt, current | 39,442 | 34,876 |
| Purchased revenue liability, current | 4,303 | 4,115 |
| Current portion of operating lease liabilities | 740 | 714 |
| Total current liabilities | 275,744 | 259,635 |
| Long-term portion of deferred consideration | 2,343 | 2,448 |
| Debt, net of issuance costs | - | 845 |
| Purchased revenue liability, net of current portion | 2,997 | 2,685 |
| Derivative liabilities | 7,894 | 18,303 |
| Operating lease liabilities, net of current portion | 1,327 | 1,523 |
| Other long-term liabilities | 155 | 155 |
| Total liabilities | 290,460 | 285,594 |
| Commitments and contingencies (See Note 11) | ||
| Stockholders’ deficit: | ||
| Preferred stock, $0.0001 par value, 45,000,000 shares authorized | ||
| Series A, 29,057,097 shares issued and outstanding as of each of March 31, 2025 and December 31, 2024 | — | — |
| Series 1, 5,000,000 shares declared as a stock dividend, not yet distributed as of each of March 31, 2025 and December 31, 2024 | 1 | 1 |
| Common stock, $0.0001 par value, 740,000,000 shares authorized; 6,951,622 shares issued and 5,493,359 shares outstanding as of March 31, 2025; 6,951,622 shares issued and 5,235,377 shares outstanding as of December 31, 2024 | 1 | 1 |
| Additional paid-in capital | 448,244 | 454,614 |
| Accumulated other comprehensive income | 6,317 | 6,317 |
| Accumulated deficit | (589,132) | (563,052) |
| Treasury stock, at cost; 1,458,263 and 1,716,245 shares as of March 31, 2025 and December 31, 2024, respectively | (76,915) | (90,522) |
| Total stockholders’ deficit | (211,484) | (192,641) |
| Total liabilities and stockholders’ deficit | $78,976 | $92,953 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.